Insight Pharma Reports Announces Ocular Disorders: Rising Therapeutics, Technologies, and Devices

NEEDHAM, MASS. - Cambridge Healthtech Institute's Insight Pharma Reports announces Ocular Disorders: Rising Therapeutics, Technologies, and Devices.

The newly released Insight Pharma Report covers a handful of companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications. In an interview with several companies including Oraya Therapeutics, Kala Pharmaceuticals, Omeros, and VisionCare, representatives mentioned several technologies and devices in development for the treatment of ocular disorders, primarily wet AMD, and some for even dry AMD. Their approaches to these therapies also differ from one another and include: radiation therapy, implantable telescope technology, PharmacoSurgery, and mucosal penetrating products. 

Specific highlights of this report include extensive research, company backgrounds, challenges, and validation techniques for therapeutic applications offered by the participating companies. These techniques include: 

• Radiation therapy
• Implantable telescope technology
• PharmacoSurgery
• Mucosal penetrating products

Also included in this report is a demographic survey of researchers working in ocular disorders. Some of the concepts include ocular areas of research, promising therapeutic options, targets of interest, and challenges encountered.

 For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com or contact Kerri Simpson at ksimpson@healthtech.com or 781-972-1347.

About Insight Pharma Reports 

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  http://www.InsightPharmaReports.com
 

Insight Pharma Reports offers ourAffiliated Reports Collectionwhich provides a repository of additional scientific and business resources. For more information, visithttp://www.insightpharmareports.com/affiliatedreports/